Manolo Carta

6.5k total citations · 1 hit paper
86 papers, 4.7k citations indexed

About

Manolo Carta is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Manolo Carta has authored 86 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Cellular and Molecular Neuroscience, 39 papers in Neurology and 21 papers in Molecular Biology. Recurrent topics in Manolo Carta's work include Parkinson's Disease Mechanisms and Treatments (38 papers), Neuroscience and Neuropharmacology Research (37 papers) and Neurotransmitter Receptor Influence on Behavior (24 papers). Manolo Carta is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (38 papers), Neuroscience and Neuropharmacology Research (37 papers) and Neurotransmitter Receptor Influence on Behavior (24 papers). Manolo Carta collaborates with scholars based in Italy, Sweden and United States. Manolo Carta's co-authors include Anders Björklund, Deniz Kirik, Thomas Carlsson, Elisabetta Tronci, Roberto Stancampiano, Erwan Bézard, Alessandro Usiello, Ana Muñoz, Gilberto Fisone and Martin Lundblad and has published in prestigious journals such as Journal of Neuroscience, Brain and Scientific Reports.

In The Last Decade

Manolo Carta

86 papers receiving 4.6k citations

Hit Papers

Dopamine released from 5-HT terminals is the cause of L-D... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manolo Carta Italy 36 3.1k 2.4k 1.4k 456 303 86 4.7k
Thomas M. Engber United States 34 3.8k 1.2× 2.2k 0.9× 1.9k 1.4× 670 1.5× 175 0.6× 61 5.3k
Charles K. Meshul United States 39 2.7k 0.9× 1.7k 0.7× 1.5k 1.1× 516 1.1× 309 1.0× 130 4.9k
Marc Savasta France 39 3.4k 1.1× 2.7k 1.1× 966 0.7× 707 1.6× 168 0.6× 86 4.8k
John T. Slevin United States 32 1.4k 0.5× 1.2k 0.5× 929 0.7× 534 1.2× 277 0.9× 93 3.3k
Veronica Ghiglieri Italy 37 2.7k 0.9× 2.3k 0.9× 1.0k 0.8× 716 1.6× 212 0.7× 78 4.8k
Wayne A. Cass United States 39 3.5k 1.1× 1.6k 0.6× 1.7k 1.2× 595 1.3× 662 2.2× 82 5.5k
Wendy R. Galpern United States 26 1.3k 0.4× 1.3k 0.5× 686 0.5× 502 1.1× 306 1.0× 51 2.8k
Paul R. Sanberg United States 38 2.6k 0.8× 894 0.4× 1.8k 1.3× 413 0.9× 438 1.4× 113 4.0k
Andréas Hartmann France 30 1.4k 0.4× 1.6k 0.6× 1.0k 0.8× 432 0.9× 112 0.4× 47 3.4k
Marc Morissette Canada 43 3.0k 1.0× 2.2k 0.9× 1.1k 0.8× 341 0.7× 123 0.4× 132 5.4k

Countries citing papers authored by Manolo Carta

Since Specialization
Citations

This map shows the geographic impact of Manolo Carta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manolo Carta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manolo Carta more than expected).

Fields of papers citing papers by Manolo Carta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manolo Carta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manolo Carta. The network helps show where Manolo Carta may publish in the future.

Co-authorship network of co-authors of Manolo Carta

This figure shows the co-authorship network connecting the top 25 collaborators of Manolo Carta. A scholar is included among the top collaborators of Manolo Carta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manolo Carta. Manolo Carta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marano, Massimo, Andrea Pilotto, Alessandro Padovani, et al.. (2024). The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson’s disease. Journal of Neurology. 271(7). 3711–3720. 3 indexed citations
2.
Valsecchi, Valeria, Francesco Errico, Valentina Bassareo, et al.. (2023). SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy. Communications Biology. 6(1). 1155–1155. 8 indexed citations
3.
Serra, Marcello, Anna Maio, Valentina Bassareo, et al.. (2023). Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration. Neurobiology of Disease. 184. 106226–106226. 12 indexed citations
4.
Scheggi, Simona, Donatella Caruso, Mauro Gentile, et al.. (2023). Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease. Experimental Neurology. 363. 114370–114370. 11 indexed citations
5.
Maio, Anna, Tommaso Nuzzo, Luana Gilio, et al.. (2023). Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients. Neurobiology of Disease. 184. 106203–106203. 19 indexed citations
6.
Errico, Francesco, Carmen Marino, Manuela Grimaldi, et al.. (2022). Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy. Biomolecules. 12(10). 1431–1431. 15 indexed citations
7.
Waters, Nicholas, Clas Sonesson, Peder Svensson, et al.. (2020). Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease. Journal of Pharmacology and Experimental Therapeutics. 374(1). 113–125. 18 indexed citations
8.
Cocco, Cristina, G Corda, Barbara Noli, et al.. (2019). VGF peptides as novel biomarkers in Parkinson’s disease. Cell and Tissue Research. 379(1). 93–107. 21 indexed citations
9.
Nuzzo, Tommaso, Daniela Punzo, Paola Devoto, et al.. (2019). The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients. Scientific Reports. 9(1). 8898–8898. 41 indexed citations
10.
Tronci, Elisabetta, Camino Fidalgo, Elisa Zianni, et al.. (2014). Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease. Neuroscience. 265. 245–252. 33 indexed citations
11.
Bézard, Erwan, Ana Muñoz, Elisabetta Tronci, et al.. (2013). Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia. Neuroscience Research. 77(4). 242–246. 38 indexed citations
12.
Carta, Manolo, et al.. (2012). Quality of Life and Psychiatric Symptoms in Wilson’s Disease: the Relevance of Bipolar Disorders. Clinical Practice and Epidemiology in Mental Health. 8(1). 102–109. 51 indexed citations
13.
Tronci, Elisabetta, Eunju Shin, Anders Björklund, & Manolo Carta. (2012). Amphetamine-induced rotation and l-DOPA-induced dyskinesia in the rat 6-OHDA model: A correlation study. Neuroscience Research. 73(2). 168–172. 24 indexed citations
14.
Errico, Francesco, Alessandra Bonito-Oliva, Vincenza Bagetta, et al.. (2011). Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate l-DOPA-induced dyskinesia. Experimental Neurology. 232(2). 240–250. 33 indexed citations
15.
Carta, Manolo, Thomas Carlsson, Ana Muñoz, Deniz Kirik, & Anders Björklund. (2010). Role of serotonin neurons in the induction of levodopa‐ and graft‐induced dyskinesias in Parkinson's disease. Movement Disorders. 25(S1). S174–9. 63 indexed citations
16.
Santini, Emanuela, Emmanuel Valjent, Alessandro Usiello, et al.. (2007). Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced Dyskinesia. Journal of Neuroscience. 27(26). 6995–7005. 349 indexed citations
17.
Carlsson, Thomas, Manolo Carta, Christian Winkler, Anders Björklund, & Deniz Kirik. (2007). Serotonin Neuron Transplants Exacerbate l-DOPA- Induced Dyskinesias in a Rat Model of Parkinson's Disease. Journal of Neuroscience. 27(30). 8011–8022. 158 indexed citations
18.
Carta, Manolo, Thomas Carlsson, Deniz Kirik, & Anders Björklund. (2007). Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain. 130(7). 1819–1833. 511 indexed citations breakdown →
19.
Carta, Manolo, Maria Collu, F Fadda, & Roberto Stancampiano. (2006). Augmented cocaine-induced accumbal dopamine efflux, motor activity and place preference in rats fed with a tryptophan-deficient diet. Neuroscience Letters. 401(1-2). 125–129. 7 indexed citations
20.
Carta, Manolo, et al.. (2001). Adjunctive gabapentin in patients with intellectual disability and bipolar spectrum disorders. Journal of Intellectual Disability Research. 45(2). 139–145. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026